Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-05-02 4:02 pm Purchase | 13G | Bicycle Therapeutics plc BCYC | Logos Global Management LP | 1,550,000 5.2% | 680,000 (+78.16%) | View |
| 2022-03-14 09:29 am Sale | 13D | Bicycle Therapeutics plc BCYC | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,408,259 4.8% | -549,702 (-28.08%) | View |
| 2022-02-14 4:40 pm Purchase | 13G | Bicycle Therapeutics plc BCYC | Point72 Asset Management, L.P. | 1,572,823 5.3% | 135,247 (+9.41%) | View |
| 2022-02-14 4:13 pm Purchase | 13G | Bicycle Therapeutics plc BCYC | Ridgeback Capital Investments L.P. | 2,164,801 7.4% | 302,968 (+16.27%) | View |
| 2022-02-14 3:16 pm Sale | 13G | Bicycle Therapeutics plc BCYC | Logos Global Management LP | 870,000 3% | -630,000 (-42.00%) | View |
| 2022-02-11 4:32 pm Sale | 13G | Bicycle Therapeutics plc BCYC | Novartis Bioventures Ltd | 673,360 2.29% | -967,786 (-58.97%) | View |
| 2022-02-11 1:58 pm Purchase | 13G | Bicycle Therapeutics plc BCYC | JANUS HENDERSON GROUP PLC JHG | 1,695,409 5.8% | 1,695,409 (New Position) | View |
| 2022-01-27 4:35 pm Purchase | 13G | Bicycle Therapeutics plc BCYC | Deep Track Capital, LP | 1,496,138 5.09% | 1,496,138 (New Position) | View |
| 2021-09-16 5:22 pm Sale | 13D | Bicycle Therapeutics plc BCYC | GSK PLC | 1,529,561 6% | -86,734 (-5.37%) | View |
| 2021-08-16 11:19 am Sale | 13D | Bicycle Therapeutics plc BCYC | SVLSF V, LLC | 1,562,451 6.49% | -352,823 (-18.42%) | View |
| 2021-07-28 7:32 pm Purchase | 13G | Bicycle Therapeutics plc BCYC | Logos Global Management LP | 1,500,000 6.2% | 1,500,000 (New Position) | View |
| 2021-04-16 4:17 pm Sale | 13D | Bicycle Therapeutics plc BCYC | GSK PLC | 1,616,295 7% | -278,536 (-14.70%) | View |
| 2021-02-16 4:17 pm Purchase | 13G | Bicycle Therapeutics plc BCYC | Ridgeback Capital Investments L.P. | 1,861,833 8.7% | 717,200 (+62.66%) | View |
| 2021-02-16 3:25 pm Purchase | 13G | Bicycle Therapeutics plc BCYC | Point72 Asset Management, L.P. | 1,437,576 6.7% | 334,600 (+30.34%) | View |
| 2021-02-02 1:00 pm Sale | 13G | Bicycle Therapeutics plc BCYC | Atlas Venture Fund VIII, L.P. | 612,696 2.88% | -750,000 (-55.04%) | View |
| 2021-02-01 5:14 pm Sale | 13G | Bicycle Therapeutics plc BCYC | Novartis Bioventures Ltd | 1,641,146 7.7% | -126,995 (-7.18%) | View |
| 2021-01-20 4:30 pm Sale | 13D | Bicycle Therapeutics plc BCYC | Vertex Global HC Fund I Pte. Ltd. | 883,475 4.15% | -737,693 (-45.50%) | View |
| 2020-12-07 5:06 pm Sale | 13D | Bicycle Therapeutics plc BCYC | GSK PLC | 1,894,831 8.9% | -20,444 (-1.07%) | View |
| 2020-11-12 09:11 am Unchanged | 13D | Bicycle Therapeutics plc BCYC | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,957,961 9.2% | 0 (Unchanged) | View |
| 2020-09-15 4:32 pm Purchase | 13G | Bicycle Therapeutics plc BCYC | Point72 Asset Management, L.P. | 1,102,976 5.7% | 1,102,976 (New Position) | View |